4.74
Schlusskurs vom Vortag:
$4.30
Offen:
$4.31
24-Stunden-Volumen:
31,909
Relative Volume:
0.12
Marktkapitalisierung:
$5.53M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-8.82M
KGV:
-0.00686
EPS:
-691.4213
Netto-Cashflow:
$-8.08M
1W Leistung:
-23.55%
1M Leistung:
-5.20%
6M Leistung:
+52.41%
1J Leistung:
-6.88%
Endra Life Sciences Inc Stock (NDRA) Company Profile
Firmenname
Endra Life Sciences Inc
Sektor
Branche
Telefon
734-335-0468
Adresse
3600 GREEN COURT, ANN ARBOR, MI
Vergleichen Sie NDRA mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
|
NDRA
Endra Life Sciences Inc
|
4.74 | 5.02M | 0 | -8.82M | -8.08M | -691.42 |
|
TMO
Thermo Fisher Scientific Inc
|
586.07 | 220.72B | 43.74B | 6.58B | 6.11B | 17.31 |
|
DHR
Danaher Corp
|
226.98 | 160.62B | 24.27B | 3.50B | 5.02B | 4.8589 |
|
IDXX
Idexx Laboratories Inc
|
752.14 | 57.96B | 4.17B | 1.03B | 940.22M | 12.61 |
|
A
Agilent Technologies Inc
|
153.60 | 42.88B | 6.79B | 1.22B | 1.09B | 4.2644 |
|
IQV
Iqvia Holdings Inc
|
228.18 | 38.30B | 15.90B | 1.28B | 2.21B | 7.2842 |
Endra Life Sciences Inc Aktie (NDRA) Neueste Nachrichten
ENDRA Life Sciences (NASDAQ: NDRA) Advances - openPR.com
ENDRA Life Sciences (NASDAQ: NDRA) Advances “Yield-to-Innovation” Strategy to Accelerate Breakthrough Liver Imaging Technology - Barchart.com
ENDRA Life Sciences (NASDAQ:NDRA) Rating Increased to Sell at Wall Street Zen - Defense World
How Market Conditions Affect Cigniti Technologies Limiteds Growth StrategyHigh Beta Stocks & Double Digit Capital Growth - earlytimes.in
How strong is ENDRA Life Sciences Inc. stock revenue growth2025 Winners & Losers & Detailed Earnings Play Strategies - newser.com
ENDRA Feasibility Study Demonstrates TAEUS® Accurately Quantifies Liver Fat Fraction, a Key MASLD/MASH Biomarker - BioSpace
ENDRA’s liver fat measurement device shows strong correlation with MRI By Investing.com - Investing.com Nigeria
ENDRA Life Sciences Inc. (NDRA) -21.7% in Normal Trading: Significant Drop Amid Recent Study Announcement - Stocks Telegraph
ENDRA’s liver fat measurement device shows strong correlation with MRI - Investing.com
How ENDRA Life Sciences Inc. stock performs during Fed tightening cyclesJuly 2025 Fed Impact & Daily Market Momentum Tracking - newser.com
Can ENDRA Life Sciences Inc. rally from current levels2025 Bull vs Bear & Technical Pattern Based Buy Signals - newser.com
What dividend safety score for ENDRA Life Sciences Inc. stock2025 Investor Takeaways & Consistent Growth Stock Picks - newser.com
ENDRA Life Sciences Inc. stock daily chart insights2025 Winners & Losers & Technical Pattern Based Buy Signals - newser.com
Why ENDRA Life Sciences Inc. stock remains resilientJuly 2025 Gainers & Weekly Sector Rotation Insights - newser.com
When is the best time to exit ENDRA Life Sciences Inc.Market Volume Summary & Fast Exit and Entry Strategy Plans - newser.com
How institutional ownership impacts ENDRA Life Sciences Inc. stockJuly 2025 Price Swings & Daily Chart Pattern Signal Reports - newser.com
Combining machine learning predictions for ENDRA Life Sciences Inc.2025 Trading Recap & Fast Exit and Entry Strategy Plans - newser.com
Editor: 【Market Analysis】 - newser.com
The New Era of Treasury Strategy: ENDRA Life Sciences (NASDAQ: NDRA) Impacting Healthcare - openPR.com
Endra Life Sciences Q3 cash burn declines on cost optimization - MarketScreener
ENDRA Life Sciences Q3 cash burn declines on cost optimization - TradingView
ENDRA Life Sciences Recaps Major Milestones and New Strategic Initiatives, Announces Third Quarter 2025 Financial Results - Business Wire
ENDRA Life Sciences Granted Nasdaq Compliance Extension - MSN
Can ENDRA Life Sciences Inc. stock beat market expectations this quarterMarket Activity Summary & Risk Controlled Swing Trade Alerts - newser.com
Can ENDRA Life Sciences Inc. recover in the next quarterPortfolio Update Report & Free Expert Verified Stock Movement Alerts - newser.com
What the charts say about ENDRA Life Sciences Inc. todayJuly 2025 Gainers & Comprehensive Market Scan Reports - newser.com
ENDRA Life Sciences Reports Q3 2025 Financial Results - The Globe and Mail
ENDRA Life Sciences Inc. SEC 10-Q Report - TradingView
ENDRA Life Sciences Regains Nasdaq Compliance - TradingView
Published on: 2025-11-14 14:59:14 - newser.com
Endra Life Sciences commences staking of HYPE digital asset holdings - Yahoo Finance
ENDRA Life Sciences Inc. (NASDAQ: NDRA) Digital Asset Tokenization to Drive Long-Term Shareholder Value - Barchart.com
What to expect from ENDRA Life Sciences Inc. in the next 30 daysInsider Selling & Reliable Breakout Forecasts - newser.com
Finanzdaten der Endra Life Sciences Inc-Aktie (NDRA)
Umsatz
Nettogewinn
Free Cashflow
ENV
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):